Showing 1 - 5 of 5 trials – Showing only trials currently accepting patients
-
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
Stanford is currently accepting patients for this trial. -
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
Stanford is currently accepting patients for this trial. -
A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in Treatment of Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias or Solid Tumors
Stanford is currently accepting patients for this trial. -
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Stanford is currently accepting patients for this trial. -
Neuroblastoma Biology Study
Stanford is currently accepting patients for this trial.